Search for: "Doe v. Mylan Pharmaceuticals, Inc." Results 81 - 100 of 163
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Sep 2011, 6:41 am by Bexis
Mylan Bertek Pharmaceuticals, Inc., Civil No. 09-690 (JNE/JSM), 2010 WL 2519988 (D. [read post]
4 Mar 2016, 12:25 pm by Dennis Crouch
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
18 Jul 2014, 11:55 am
Wyeth Pharmaceuticals, Inc., 2008 WL 7136137 (Ala. [read post]
20 May 2013, 11:52 pm by Lawrence B. Ebert
Mylan concerning fexofenadine.The decision is by a 2-1 vote.The initial part of the decision:Aventis Pharmaceuticals, Inc. and Albany MolecularResearch, Inc. [read post]
18 Apr 2016, 9:58 am by Dennis Crouch
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
Alfonso Cioffi, No. 16-200 (holding prosecution history against the patentee) Civil Procedure – Personal Jurisdiction: Mylan Pharmaceuticals, et al. v. [read post]
13 Oct 2014, 9:01 am by Lyle Denniston
Wednesday, the Supreme Court will hold one hour of oral argument on a high-stakes legal battle between a brand-name drug company and a group of companies making generic drugs – Teva Pharmaceuticals USA v. [read post]
15 Apr 2010, 9:20 am by Bexis
Cir. 1996) (not an FDCA case); Mylan Laboratories, Inc. v. [read post]
22 Mar 2011, 4:21 pm by Marie Louise
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly…  well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany:… [read post]
18 Jan 2013, 2:06 pm by Bexis
  The Decherts are too involved in this litigation to comment publicly.There aren’t many research-oriented pharmaceutical companies based in Alabama, and after last week’s execrable decision in Wyeth, Inc. v. [read post]
12 Apr 2017, 9:52 am by Lawrence B. Ebert
(collectively, Novartis).The Board instituted IPRs on all claims of the ’283 patentbased on petitions filed by Torrent PharmaceuticalsLimited, Apotex, Inc. and Mylan Pharmaceuticals Inc. [read post]